# Climb Global Solutions, Inc.: financial statements, quarterly

CLMB · Nasdaq · CIK 945983 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clmb.md) · [Financials](/companies/clmb/financials.md) · [Filings](/companies/clmb/filings.md) · [Insiders](/companies/clmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clmb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [107 d](/filings/0001558370-24-002476.md) | [92.4](/filings/0001558370-24-006567.md) | [92.1](/filings/0001437749-25-024179.md) | [119](/filings/0001437749-25-032397.md) | [162 d](/filings/0001437749-26-006072.md) | [138](/filings/0001437749-26-014225.md) | [159](/filings/0001437749-26-025052.md) | [161](/filings/0001437749-26-033931.md) | [194 d](/filings/0001437749-26-006072.md) | [182](/filings/0001437749-26-014225.md) | [174](/filings/0001437749-26-025052.md) | [220](/filings/0001437749-26-033931.md) |
| Cost of revenue | $m | [85.7 d](/filings/0001558370-24-002476.md) | [75.4](/filings/0001558370-24-006567.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [21.1 d](/filings/0001437749-26-006072.md) | [17.0](/filings/0001437749-25-014103.md) | [18.6](/filings/0001437749-25-024179.md) | [24.3](/filings/0001437749-25-032397.md) | [31.2 d](/filings/0001437749-26-006072.md) | [23.4](/filings/0001437749-26-014225.md) | [26.3](/filings/0001437749-26-025052.md) | [25.7](/filings/0001437749-26-033931.md) | [29.8 d](/filings/0001437749-26-006072.md) | [26.5](/filings/0001437749-26-014225.md) | [30.2](/filings/0001437749-26-025052.md) | [33.0](/filings/0001437749-26-033931.md) |
| Selling, general and administrative | $m | [12.4 d](/filings/0001437749-26-006072.md) | [12.5](/filings/0001437749-25-014103.md) | [13.0](/filings/0001437749-25-024179.md) | [13.9](/filings/0001437749-25-032397.md) | [17.1 d](/filings/0001437749-26-006072.md) | [16.8](/filings/0001437749-26-014225.md) | [16.4](/filings/0001437749-26-025052.md) | [16.2](/filings/0001437749-26-033931.md) | [18.2 d](/filings/0001437749-26-006072.md) | [20.3](/filings/0001437749-26-014225.md) | [20.7](/filings/0001437749-26-025052.md) | [20.9](/filings/0001437749-26-033931.md) |
| Operating income | $m | [7.5 d](/filings/0001437749-26-006072.md) | [3.5](/filings/0001437749-25-014103.md) | [4.3](/filings/0001437749-25-024179.md) | [8.5](/filings/0001437749-25-032397.md) | [11.7 d](/filings/0001437749-26-006072.md) | [4.8](/filings/0001437749-26-014225.md) | [8.0](/filings/0001437749-26-025052.md) | [6.9](/filings/0001437749-26-033931.md) | [9.5 d](/filings/0001437749-26-006072.md) | [3.9](/filings/0001437749-26-014225.md) | [7.4](/filings/0001437749-26-025052.md) | [10.0](/filings/0001437749-26-033931.md) |
| Income tax | $m | [1.8 d](/filings/0001437749-26-006072.md) | [0.9](/filings/0001437749-25-014103.md) | [1.0](/filings/0001437749-25-024179.md) | [1.7](/filings/0001437749-25-032397.md) | [2.8 d](/filings/0001437749-26-006072.md) | [0.6](/filings/0001437749-26-014225.md) | [1.8](/filings/0001437749-26-025052.md) | [1.6](/filings/0001437749-26-033931.md) | [2.6 d](/filings/0001437749-26-006072.md) | [0.8](/filings/0001437749-26-014225.md) | [2.0](/filings/0001437749-26-025052.md) | [2.9](/filings/0001437749-26-033931.md) |
| Net income | $m | [5.2 d](/filings/0001437749-26-006072.md) | [2.7](/filings/0001437749-25-032397.md) | [3.4](/filings/0001437749-25-032397.md) | [5.5](/filings/0001437749-25-032397.md) | [7.0 d](/filings/0001437749-26-006072.md) | [3.7](/filings/0001437749-26-033931.md) | [6.0](/filings/0001437749-26-033931.md) | [4.7](/filings/0001437749-26-033931.md) | [7.0 d](/filings/0001437749-26-006072.md) | [3.3](/filings/0001437749-26-033931.md) | [5.5](/filings/0001437749-26-033931.md) | [7.9](/filings/0001437749-26-033931.md) |
| Diluted EPS | $ per share | not reported | [0.60](/filings/0001437749-25-014103.md) | [0.75](/filings/0001437749-25-024179.md) | [1.19](/filings/0001437749-25-032397.md) | not reported | [0.20](/filings/0001437749-26-014225.md) | [0.33](/filings/0001437749-26-025052.md) | [0.25](/filings/0001437749-26-033931.md) | not reported | [0.18](/filings/0001437749-26-014225.md) | [0.30](/filings/0001437749-26-025052.md) | [0.43](/filings/0001437749-26-033931.md) |
| Basic EPS | $ per share | not reported | [0.60](/filings/0001437749-25-014103.md) | [0.75](/filings/0001437749-25-024179.md) | [1.19](/filings/0001437749-25-032397.md) | not reported | [0.20](/filings/0001437749-26-014225.md) | [0.33](/filings/0001437749-26-025052.md) | [0.25](/filings/0001437749-26-033931.md) | not reported | [0.18](/filings/0001437749-26-014225.md) | [0.30](/filings/0001437749-26-025052.md) | [0.43](/filings/0001437749-26-033931.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.3](/filings/0001437749-25-006986.md) | [43.6](/filings/0001558370-24-006567.md) | [48.4](/filings/0001437749-24-025120.md) | [22.1](/filings/0001437749-24-032952.md) | [29.8](/filings/0001437749-26-006072.md) | [32.5](/filings/0001437749-25-014103.md) | [28.6](/filings/0001437749-25-024179.md) | [49.8](/filings/0001437749-25-032397.md) | [36.6](/filings/0001437749-26-033931.md) | [41.8](/filings/0001437749-26-014225.md) | [56.6](/filings/0001437749-26-025052.md) | [66.9](/filings/0001437749-26-033931.md) |
| Current assets | $m | [269](/filings/0001437749-25-006986.md) | [233](/filings/0001558370-24-006567.md) | [237](/filings/0001437749-24-025120.md) | [281](/filings/0001437749-24-032952.md) | [381](/filings/0001437749-26-006072.md) | [281](/filings/0001437749-25-014103.md) | [330](/filings/0001437749-25-024179.md) | [288](/filings/0001437749-25-032397.md) | [374](/filings/0001437749-26-033931.md) | [364](/filings/0001437749-26-014225.md) | [369](/filings/0001437749-26-025052.md) | [427](/filings/0001437749-26-033931.md) |
| Total assets | $m | [335](/filings/0001437749-25-006986.md) | [298](/filings/0001558370-24-006567.md) | [303](/filings/0001437749-24-025120.md) | [372](/filings/0001437749-24-032952.md) | [469](/filings/0001437749-26-006072.md) | [370](/filings/0001437749-25-014103.md) | [421](/filings/0001437749-25-024179.md) | [376](/filings/0001437749-25-032397.md) | [460](/filings/0001437749-26-033931.md) | [459](/filings/0001437749-26-014225.md) | [462](/filings/0001437749-26-025052.md) | [518](/filings/0001437749-26-033931.md) |
| Current liabilities | $m | [251](/filings/0001437749-25-006986.md) | [214](/filings/0001558370-24-006567.md) | [216](/filings/0001437749-24-025120.md) | [275](/filings/0001437749-24-032952.md) | [372](/filings/0001437749-26-006072.md) | [268](/filings/0001437749-25-014103.md) | [309](/filings/0001437749-25-024179.md) | [260](/filings/0001437749-25-032397.md) | [337](/filings/0001437749-26-033931.md) | [330](/filings/0001437749-26-014225.md) | [328](/filings/0001437749-26-025052.md) | [375](/filings/0001437749-26-033931.md) |
| Total liabilities | $m | [260](/filings/0001437749-25-006986.md) | [222](/filings/0001558370-24-006567.md) | [223](/filings/0001437749-24-025120.md) | [284](/filings/0001437749-24-032952.md) | [379](/filings/0001437749-26-006072.md) | [274](/filings/0001437749-25-014103.md) | [316](/filings/0001437749-25-024179.md) | [267](/filings/0001437749-25-032397.md) | [344](/filings/0001437749-26-033931.md) | [340](/filings/0001437749-26-014225.md) | [338](/filings/0001437749-26-025052.md) | [384](/filings/0001437749-26-033931.md) |
| Long-term debt | $m | [0.8](/filings/0001437749-25-006986.md) | [1.2](/filings/0001558370-24-006567.md) | [0.5](/filings/0001437749-24-025120.md) | [0.3](/filings/0001437749-24-032952.md) | [0.2](/filings/0001437749-26-006072.md) | [0.0](/filings/0001437749-25-014103.md) | [0.0](/filings/0001437749-25-024179.md) | [0.0](/filings/0001437749-25-032397.md) | [0.0](/filings/0001437749-26-006072.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [0.5](/filings/0001437749-25-006986.md) | not reported | [0.6](/filings/0001437749-24-025120.md) | [0.6](/filings/0001437749-24-032952.md) | [0.6](/filings/0001437749-26-006072.md) | [0.6](/filings/0001437749-25-014103.md) | [0.5](/filings/0001437749-25-024179.md) | [0.3](/filings/0001437749-25-032397.md) | [0.2](/filings/0001437749-26-033931.md) | [0.0](/filings/0001437749-26-014225.md) | [0.0](/filings/0001437749-26-025052.md) | [0.0](/filings/0001437749-26-033931.md) |
| Shareholders' equity | $m | [74.8](/filings/0001437749-26-006072.md) | [76.4](/filings/0001437749-25-032397.md) | [79.8](/filings/0001437749-25-032397.md) | [87.7](/filings/0001437749-25-032397.md) | [90.6](/filings/0001437749-26-033931.md) | [95.6](/filings/0001437749-26-033931.md) | [105](/filings/0001437749-26-033931.md) | [109](/filings/0001437749-26-033931.md) | [117](/filings/0001437749-26-033931.md) | [118](/filings/0001437749-26-033931.md) | [125](/filings/0001437749-26-033931.md) | [134](/filings/0001437749-26-033931.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.8 d](/filings/0001437749-26-006072.md) | [14.0](/filings/0001437749-25-014103.md) | [7.3 d](/filings/0001437749-25-024179.md) | [(3.6) d](/filings/0001437749-25-032397.md) | [16.0 d](/filings/0001437749-26-006072.md) | [8.5](/filings/0001437749-26-014225.md) | [(2.2) d](/filings/0001437749-26-025052.md) | [22.2 d](/filings/0001437749-26-033931.md) | [(11.9) d](/filings/0001437749-26-006072.md) | [16.8](/filings/0001437749-26-014225.md) | [15.4 d](/filings/0001437749-26-025052.md) | [11.9 d](/filings/0001437749-26-033931.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [0.7](/filings/0001437749-26-014225.md) | [0.7 d](/filings/0001437749-26-025052.md) | [0.3 d](/filings/0001437749-26-033931.md) | not reported | [0.5](/filings/0001437749-26-014225.md) | [0.5 d](/filings/0001437749-26-025052.md) | [0.8 d](/filings/0001437749-26-033931.md) |
| Dividends paid | $m | [0.8 d](/filings/0001558370-24-002476.md) | [0.8](/filings/0001558370-24-006567.md) | [0.8 d](/filings/0001437749-25-024179.md) | [0.8 d](/filings/0001437749-25-032397.md) | [0.8 d](/filings/0001437749-26-006072.md) | [0.8](/filings/0001437749-26-014225.md) | [0.8 d](/filings/0001437749-26-025052.md) | [0.8 d](/filings/0001437749-26-033931.md) | [0.8 d](/filings/0001437749-26-006072.md) | [0.0](/filings/0001437749-26-014225.md) | [0.0 d](/filings/0001437749-26-025052.md) | [0.0 d](/filings/0001437749-26-033931.md) |
| Share repurchases | $m | [0.3 d](/filings/0001437749-26-006072.md) | [0.4](/filings/0001437749-25-014103.md) | [0.3 d](/filings/0001437749-25-024179.md) | [0.3 d](/filings/0001437749-25-032397.md) | [0.6 d](/filings/0001437749-26-006072.md) | [0.9](/filings/0001437749-26-014225.md) | [0.5 d](/filings/0001437749-26-025052.md) | [0.3 d](/filings/0001437749-26-033931.md) | [0.3 d](/filings/0001437749-26-006072.md) | [1.5](/filings/0001437749-26-014225.md) | [0.1 d](/filings/0001437749-26-025052.md) | [0.2 d](/filings/0001437749-26-033931.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.4](/filings/0001558370-24-006567.md) | [4.4](/filings/0001437749-24-025120.md) | [4.4](/filings/0001437749-24-032952.md) | [4.4](/filings/0001437749-25-014103.md) | [4.5](/filings/0001437749-25-024179.md) | [4.5](/filings/0001437749-25-032397.md) | [18.0](/filings/0001437749-26-014225.md) | [18.1](/filings/0001437749-26-025052.md) | [18.1](/filings/0001437749-26-033931.md) | [18.2](/filings/0001437749-26-014225.md) | [18.3](/filings/0001437749-26-025052.md) | [18.3](/filings/0001437749-26-033931.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,657,963 at 2026-10-29, from the cover of the [10-Q filed 2026-10-29](/filings/0001437749-26-033931.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:09 ET. No prices; not investment advice.